Article info
PDFLetters
Antibodies to domain I of β-2-glycoprotein I and IgA antiphospholipid antibodies in patients with ‘seronegative’ antiphospholipid syndrome
- Correspondence to Professor Anisur Rahman, Centre for Rheumatology Research, Division of Medicine, Fourth Floor Rayne Institute, 5 University Street, London WC1E 6JF, UK; anisur.rahman{at}ucl.ac.uk
Citation
Antibodies to domain I of β-2-glycoprotein I and IgA antiphospholipid antibodies in patients with ‘seronegative’ antiphospholipid syndrome
Publication history
- Received August 15, 2014
- Revised October 7, 2014
- Accepted October 12, 2014
- First published October 30, 2014.
Online issue publication
October 31, 2019
Article Versions
- Previous version (2 July 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/